ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 118 filers reported holding ATEA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $795,276 | -50.5% | 265,092 | -38.3% | 0.00% | – |
| Q2 2023 | $1,606,314 | +0.5% | 429,496 | -10.0% | 0.00% | – |
| Q1 2023 | $1,598,571 | -24.3% | 477,185 | +8.6% | 0.00% | – |
| Q4 2022 | $2,112,715 | -25.2% | 439,234 | -11.6% | 0.00% | – |
| Q3 2022 | $2,826,000 | +1.4% | 496,980 | +26.6% | 0.00% | – |
| Q2 2022 | $2,787,000 | -10.0% | 392,516 | -8.4% | 0.00% | – |
| Q1 2022 | $3,095,000 | -46.1% | 428,621 | -33.3% | 0.00% | -100.0% |
| Q4 2021 | $5,746,000 | -63.0% | 642,742 | +45.2% | 0.00% | -50.0% |
| Q3 2021 | $15,520,000 | -8.5% | 442,686 | -43.9% | 0.00% | 0.0% |
| Q2 2021 | $16,954,000 | +370.8% | 789,348 | +1253.5% | 0.00% | +100.0% |
| Q1 2021 | $3,601,000 | -19.1% | 58,321 | -45.3% | 0.00% | 0.0% |
| Q4 2020 | $4,453,000 | – | 106,587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |